BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 25938461)

  • 21. Long non-coding RNA PICSAR knockdown inhibits the progression of cutaneous squamous cell carcinoma by regulating miR-125b/YAP1 axis.
    Lu X; Gan Q; Gan C; Zheng Y; Cai B; Li X; Li D; Yin G
    Life Sci; 2021 Jun; 274():118303. PubMed ID: 32841663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MiR-214 promotes cell meastasis and inhibites apoptosis of esophageal squamous cell carcinoma via PI3K/AKT/mTOR signaling pathway.
    Guanen Q; Junjie S; Baolin W; Chaoyang W; Yajuan Y; Jing L; Junpeng L; Gaili N; Zhongping W; Jun W
    Biomed Pharmacother; 2018 Sep; 105():350-361. PubMed ID: 29864623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-135b, upregulated in breast cancer, promotes cell growth and disrupts the cell cycle by regulating LATS2.
    Hua K; Jin J; Zhao J; Song J; Song H; Li D; Maskey N; Zhao B; Wu C; Xu H; Fang L
    Int J Oncol; 2016 May; 48(5):1997-2006. PubMed ID: 26934863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-573 inhibits cell proliferation, migration and invasion and is downregulated by PICSAR in cutaneous squamous cell carcinoma.
    Wang Y; Tang S; Lv J
    Bosn J Basic Med Sci; 2022 Apr; 22(2):229-237. PubMed ID: 34905724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. APE1 promotes proliferation and migration of cutaneous squamous cell carcinoma.
    Deng X; Zhen P; Niu X; Dai Y; Wang Y; Zhou M
    J Dermatol Sci; 2020 Oct; 100(1):67-74. PubMed ID: 32951990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-125b exerts antitumor functions in cutaneous squamous cell carcinoma by targeting the STAT3 pathway.
    Tian K; Liu W; Zhang J; Fan X; Liu J; Zhao N; Yao C; Miao G
    Cell Mol Biol Lett; 2020; 25():12. PubMed ID: 32161621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-135b regulates metastasis suppressor 1 expression and promotes migration and invasion in colorectal cancer.
    Wu W; Wang Z; Yang P; Yang J; Liang J; Chen Y; Wang H; Wei G; Ye S; Zhou Y
    Mol Cell Biochem; 2014 Mar; 388(1-2):249-59. PubMed ID: 24343340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. lncRNA HCP5 acts as a ceRNA to regulate EZH2 by sponging miR‑138‑5p in cutaneous squamous cell carcinoma.
    Zou S; Gao Y; Zhang S
    Int J Oncol; 2021 Aug; 59(2):. PubMed ID: 34195851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-142-5p induces cancer stem cell-like properties of cutaneous squamous cell carcinoma via inhibiting PTEN.
    Bai X; Zhou Y; Chen P; Yang M; Xu J
    J Cell Biochem; 2018 Feb; 119(2):2179-2188. PubMed ID: 28857248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MiR-20a inhibits cutaneous squamous cell carcinoma metastasis and proliferation by directly targeting LIMK1.
    Zhou J; Liu R; Luo C; Zhou X; Xia K; Chen X; Zhou M; Zou Q; Cao P; Cao K
    Cancer Biol Ther; 2014 Oct; 15(10):1340-9. PubMed ID: 25019203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal.
    Lulli V; Buccarelli M; Martini M; Signore M; Biffoni M; Giannetti S; Morgante L; Marziali G; Ilari R; Pagliuca A; Larocca LM; De Maria R; Pallini R; Ricci-Vitiani L
    Oncotarget; 2015 Nov; 6(35):37241-56. PubMed ID: 26437223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-365 promotes cutaneous squamous cell carcinoma (CSCC) through targeting nuclear factor I/B (NFIB).
    Zhou M; Zhou L; Zheng L; Guo L; Wang Y; Liu H; Ou C; Ding Z
    PLoS One; 2014; 9(6):e100620. PubMed ID: 24949940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-497 promotes the progression of cutaneous squamous cell carcinoma through FAM114A2.
    Wei XH; Gu XL; Zhou XT; Ma M; Lou CX
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7348-7355. PubMed ID: 30468480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Upregulated circular RNA circ_0070934 facilitates cutaneous squamous cell carcinoma cell growth and invasion by sponging miR-1238 and miR-1247-5p.
    An X; Liu X; Ma G; Li C
    Biochem Biophys Res Commun; 2019 May; 513(2):380-385. PubMed ID: 30967263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long non-coding RNA SCARNA2 induces cutaneous squamous cell carcinoma progression via modulating miR-342-3p expression.
    Zhang Z; Jia M; Wen C; He A; Ma Z
    J Gene Med; 2020 Dec; 22(12):e3242. PubMed ID: 32558970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Downregulation of ARMC8 promotes tumorigenesis through activating Wnt/β-catenin pathway and EMT in cutaneous squamous cell carcinomas.
    Li X; Zhang C; Yuan Y; Wang Y; Lu S; Zhou Z; Zhen P; Zhou M
    J Dermatol Sci; 2021 Jun; 102(3):184-192. PubMed ID: 34016486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GRIM-19 represses the proliferation and invasion of cutaneous squamous cell carcinoma cells associated with downregulation of STAT3 signaling.
    Wu N; Hui H; Cui L; Yang F
    Biomed Pharmacother; 2017 Nov; 95():1169-1176. PubMed ID: 28926927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CircRNA hsa_circ_0070934 functions as a competitive endogenous RNA to regulate HOXB7 expression by sponging miR‑1236‑3p in cutaneous squamous cell carcinoma.
    Zhang DW; Wu HY; Zhu CR; Wu DD
    Int J Oncol; 2020 Aug; 57(2):478-487. PubMed ID: 32626939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alterations of microRNAs throughout the malignant evolution of cutaneous squamous cell carcinoma: the role of miR-497 in epithelial to mesenchymal transition of keratinocytes.
    Mizrahi A; Barzilai A; Gur-Wahnon D; Ben-Dov IZ; Glassberg S; Meningher T; Elharar E; Masalha M; Jacob-Hirsch J; Tabibian-Keissar H; Barshack I; Roszik J; Leibowitz-Amit R; Sidi Y; Avni D
    Oncogene; 2018 Jan; 37(2):218-230. PubMed ID: 28925390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetic Regulation of iASPP-p63 Feedback Loop in Cutaneous Squamous Cell Carcinoma.
    Robinson DJ; Patel A; Purdie KJ; Wang J; Rizvi H; Hufbauer M; Ostano P; Akgül B; Chiorino G; Harwood CA; Bergamaschi D
    J Invest Dermatol; 2019 Aug; 139(8):1658-1671.e8. PubMed ID: 30710576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.